Longevity Acquisition (LOAC) announced that it received a letter Dec. 10 from the Nasdaq’s Listing Qualifications Department, confirming that the company had regained compliance with Nasdaq Listing Rule 5550(a)(3) which requires companies to have at least 300 public holders for continued listing. This is also known as the “Minimum Public Holders Rule”.
The SPAC is contemplating a proposed business combination with 4D Pharma. Read more.
